Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Brooks Laboratories Ltd

BROOKS.NS ✓ COMPLIANT ☆ Track — members

NSE · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.64

▼ -3.28%

Market Cap $18.73M · Vol 51.53K

Key Metrics

P/E Ratio

13.60

FWD: N/A

Market Cap

$18.73M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

46.63

Momentum

Beta

2.05

vs Market

52W High

$1.64

64.47% below

52W Low

$0.38

65.30% above

Volume

51.53K

Avg 29.06K

P/B

0.89

Price-to-book

ROE

N/A

Return on equity

Free Float

44.12%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Brooks Laboratories Ltd (BROOKS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BROOKS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.60%

-2.23%

-9.09%

+7.00%

YTD

-23.86%

-61.02%

-48.93%

-58.63%

Financials & Valuation

TTM · Annual

Total Revenue	$9.17M
Net Income	$2.63M
Revenue Growth (YoY)	-10.00%
Gross Margin	34.74%
Operating Margin	6.56%
Net Profit Margin	28.67%
ROE	N/A
ROA · ROIC	18.08% · 21.36%

P/E Ratio	13.60
Forward P/E (FY1)	N/A
PEG Ratio	0.01
P/S	1.27
P/B	0.89
P/FCF	21.49
EPS Growth	N/A
Outstanding Shares	29.46M

Technical Indicators

50-Day SMA	$0.67
200-Day SMA	$0.71
RSI (14)	46.63
Beta	2.05
52-Week High	$1.64
52-Week Low	$0.38

Volume Today	51.53K
Avg Daily Volume (30D)	29.06K
Relative Volume	1.77x
Volatility (10D)	49.13
Volatility (30D)	47.65
Free Float	44.12%

Analyst Consensus

N/A

Current Price $0.64

Mean Target N/A

52W Low$0.38 52W High$1.64

Current

Target

$0.38 $1.64

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE

FIGIBBG001TG4DR8

ISININE650L01011

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd +1.01% 4578.T Otsuka Holdings Co., Ltd. -4.55% ZYDUSLIFE.NS Zydus Lifesciences Ltd +0.77% CIPLA.NS Cipla Ltd +0.52% 4528.T ONO PHARMACEUTICAL CO., LTD. -1.00%

Company Profile

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.